Literature DB >> 27390357

Baseline bone involvement in multiple myeloma - a prospective comparison of conventional X-ray, low-dose computed tomography, and 18flourodeoxyglucose positron emission tomography in previously untreated patients.

Maja Hinge1, Kristian T Andersen2, Thomas Lund3, Henrik B Jørgensen4, Paw C Holdgaard4, Tina E Ormstrup5, Lone L Østergaard5, Torben Plesner2.   

Abstract

Entities:  

Keywords:  CT; Myeloma; PET; X-ray; bone marker

Mesh：

Substances：

Year:  2016        PMID： 27390357      PMCID： PMC5046664          DOI： 10.3324/haematol.2016.146092

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Biologic and therapeutic determinants of bone mineral density in multiple myeloma.

Authors:  M V Dhodapkar; R Weinstein; G Tricot; S Jagannath; A M Parfitt; S C Manolagas; B Barlogie
Journal:  Leuk Lymphoma       Date:  1998-12

2.  Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma.

Authors:  Patric Kröpil; Roland Fenk; Lars B Fritz; Dirk Blondin; Guido Kobbe; Ulrich Mödder; Mathias Cohnen
Journal:  Eur Radiol       Date:  2007-10-09       Impact factor: 5.315

3.  European Myeloma Network guidelines for the management of multiple myeloma-related complications.

Authors:  Evangelos Terpos; Martina Kleber; Monika Engelhardt; Sonja Zweegman; Francesca Gay; Efstathios Kastritis; Niels W C J van de Donk; Benedetto Bruno; Orhan Sezer; Annemiek Broijl; Sara Bringhen; Meral Beksac; Alessandra Larocca; Roman Hajek; Pellegrino Musto; Hans Erik Johnsen; Fortunato Morabito; Heinz Ludwig; Michele Cavo; Hermann Einsele; Pieter Sonneveld; Meletios A Dimopoulos; Antonio Palumbo
Journal:  Haematologica       Date:  2015-10       Impact factor: 9.941

4.  Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.

Authors:  Marius Horger; Claus D Claussen; Ulrike Bross-Bach; Reinhard Vonthein; Tobias Trabold; Martin Heuschmid; Christina Pfannenberg
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

5.  Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

Authors:  María-Victoria Mateos; Miguel-Teodoro Hernández; Pilar Giraldo; Javier de la Rubia; Felipe de Arriba; Lucía López Corral; Laura Rosiñol; Bruno Paiva; Luis Palomera; Joan Bargay; Albert Oriol; Felipe Prosper; Javier López; Eduardo Olavarría; Nuria Quintana; José-Luis García; Joan Bladé; Juan-José Lahuerta; Jesús-F San Miguel
Journal:  N Engl J Med       Date:  2013-08-01       Impact factor: 91.245

6.  PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma.

Authors:  Elena Zamagni; Cristina Nanni; Katia Mancuso; Paola Tacchetti; Annalisa Pezzi; Lucia Pantani; Beatrice Zannetti; Ilaria Rambaldi; Annamaria Brioli; Serena Rocchi; Carolina Terragna; Marina Martello; Giulia Marzocchi; Enrica Borsi; Ilaria Rizzello; Stefano Fanti; Michele Cavo
Journal:  Clin Cancer Res       Date:  2015-06-15       Impact factor: 12.531

7.  F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma.

Authors:  Twyla B Bartel; Jeff Haessler; Tracy L Y Brown; John D Shaughnessy; Frits van Rhee; Elias Anaissie; Terri Alpe; Edgardo Angtuaco; Ronald Walker; Joshua Epstein; John Crowley; Bart Barlogie
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

8.  Comparison of modern and conventional imaging techniques in establishing multiple myeloma-related bone disease: a systematic review.

Authors:  Josien C Regelink; Monique C Minnema; Evangelos Terpos; Marjolein H Kamphuis; Pieter G Raijmakers; Indra C Pieters-van den Bos; Ben G F Heggelman; Rutger-Jan Nievelstein; Rene H J Otten; Danielle van Lammeren-Venema; Josee M Zijlstra; Anne I J Arens; Jacky W de Rooy; Otto S Hoekstra; Reinier Raymakers; Pieter Sonneveld; Raymond W Ostelo; Sonja Zweegman
Journal:  Br J Haematol       Date:  2013-04-25       Impact factor: 6.998

9.  Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).

Authors:  T G Gleeson; J Moriarty; C P Shortt; J P Gleeson; P Fitzpatrick; B Byrne; J McHugh; M O'Connell; P O'Gorman; S J Eustace
Journal:  Skeletal Radiol       Date:  2008-11-14       Impact factor: 2.199

10.  Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis.

Authors:  Thomas Lund; Niels Abildgaard; Thomas L Andersen; Jean-Marie Delaisse; Torben Plesner
Journal:  Eur J Haematol       Date:  2010-01-13       Impact factor: 2.997
View more
  8 in total

Review 1.  Whole body imaging in musculoskeletal oncology: when, why, and how.

Authors:  Joao R T Vicentini; Miriam A Bredella
Journal:  Skeletal Radiol       Date:  2022-07-09       Impact factor: 2.199

Review 2.  Modern radiographic imaging in multiple myeloma, what is the minimum requirement?

Authors:  Esther Mena; Evrim B Turkbey; Liza Lindenberg
Journal:  Semin Oncol       Date:  2022-01-20       Impact factor: 5.385

3.  Detecting Multiple Myeloma Infiltration of the Bone Marrow on CT Scans in Patients with Osteopenia: Feasibility of Radiomics Analysis.

Authors:  Hyerim Park; So-Yeon Lee; Jooyeon Lee; Juyoung Pak; Koeun Lee; Seung-Eun Lee; Joon-Yong Jung
Journal:  Diagnostics (Basel)       Date:  2022-04-07

Review 4.  Oncologist perspective: role of imaging in myeloma.

Authors:  Yael N Shapiro; Elizabeth K O'Donnell
Journal:  Skeletal Radiol       Date:  2021-07-17       Impact factor: 2.199

5.  Diagnostic performance of 18 F-FDG-PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward.

Authors:  Elizabeth Hill; Esther Mena; Candis Morrison; Alexander Dew; Peter Choyke; Liza Lindenberg; Dickran Kazandjian
Journal:  Br J Haematol       Date:  2020-09-23       Impact factor: 8.615

6.  Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group.

Authors:  J Hillengass; L A Moulopoulos; S Delorme; V Koutoulidis; J Mosebach; T Hielscher; M Drake; S V Rajkumar; B Oestergaard; N Abildgaard; M Hinge; T Plesner; Y Suehara; K Matsue; N Withofs; J Caers; A Waage; H Goldschmidt; M A Dimopoulos; S Lentzsch; B Durie; E Terpos
Journal:  Blood Cancer J       Date:  2017-08-25       Impact factor: 11.037

7.  Bone complications in patients with multiple myeloma in five European countries: a retrospective patient chart review.

Authors:  María-Victoria Mateos; Leah Fink; Niranchana Koneswaran; Michele Intorcia; Christina Giannopoulou; Daniela Niepel; Michele Cavo
Journal:  BMC Cancer       Date:  2020-03-03       Impact factor: 4.430

Review 8.  Bone Disease in Multiple Myeloma: Biologic and Clinical Implications.

Authors:  Zachary S Bernstein; E Bridget Kim; Noopur Raje
Journal:  Cells       Date:  2022-07-27       Impact factor: 7.666
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.